CANC Holdings Information

CANC is an equity ETF with a total of 51 individual holdings. The top holdings are Revolution Medicines stock at 6.37%, Eli Lilly and Company at 5.49%, Genmab at 5.04%, Roche Holding AG at 4.56%, and BridgeBio Pharma at 4.48%.

Total Holdings

Top 10 Percentage

45.51%

Asset Class

Equity

ETF Category

Health

Assets

83.50M

PE Ratio

20.39

Sector Allocation

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	RVMD	Revolution Medicines, Inc.	6.37%	111,711
2	LLY	Eli Lilly and Company	5.49%	5,351
3	GMAB	Genmab A/S	5.04%	132,043
4	RHHBY	Roche Holding AG	4.56%	83,599
5	BBIO	BridgeBio Pharma, Inc.	4.48%	68,187
6	SWX: NOVN	Novartis AG	4.25%	26,843
7	LON: AZN	AstraZeneca PLC	4.18%	20,293
8	ACLX	Arcellx, Inc.	3.90%	36,809
9	MRUS	Merus N.V.	3.76%	33,134
10	NUVL	Nuvalent, Inc.	3.48%	33,007
11	IMNM	Immunome, Inc.	2.78%	162,186
12	EXEL	Exelixis, Inc.	2.74%	59,259
13	ONC	BeOne Medicines AG	2.72%	6,771
14	BMY	Bristol-Myers Squibb Company	2.56%	47,864
15	ABBV	AbbVie Inc.	2.54%	9,191
16	ZLAB	Zai Lab Limited	2.43%	62,067
17	IDYA	IDEAYA Biosciences, Inc.	2.38%	74,269
18	GILD	Gilead Sciences, Inc.	2.38%	17,036
19	SMMT	Summit Therapeutics Inc.	2.18%	80,284
20	SNDX	Syndax Pharmaceuticals, Inc.	2.14%	110,066
21	LEGN	Legend Biotech Corporation	2.11%	54,543
22	ARGX	argenx SE	1.96%	2,031
23	AMGN	Amgen Inc.	1.81%	5,116
24	COGT	Cogent Biosciences, Inc.	1.74%	89,923
25	CGON	CG Oncology, Inc.	1.61%	30,225

Showing 25 of 51 holdings

Subscribe to see the full list

Activate Now

As of Oct 9, 2025